These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 954531)

  • 21. Cancer immunotherapy.
    Schuster M; Nechansky A; Kircheis R
    Biotechnol J; 2006 Feb; 1(2):138-47. PubMed ID: 16892244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [New method in the therapy of cancer. Interview granted to Minerva Medica by Prof. Augusto Pederzini].
    Carafa M
    Minerva Med; 1973 Apr; 64(25):3-6. PubMed ID: 4709744
    [No Abstract]   [Full Text] [Related]  

  • 23. A phase III randomized study of interleukin-2 lymphokine-activated killer cell immunotherapy combined with chemotherapy or radiotherapy after curative or noncurative resection of primary lung carcinoma.
    Kimura H; Yamaguchi Y
    Cancer; 1997 Jul; 80(1):42-9. PubMed ID: 9210707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in the treatment of malignant melanoma.
    Krementz ET; Creach O
    Proc Natl Cancer Conf; 1970; 6():529-42. PubMed ID: 5458120
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of 37 surgical cancers with associated or isolated chemotherapy].
    Montezin J
    Bull Mem Soc Chir Paris; 1971; 61(6):352-68. PubMed ID: 5152093
    [No Abstract]   [Full Text] [Related]  

  • 26. [Biotherapy of solid tumors].
    Moiseenko VM
    Vopr Onkol; 1998; 44(1):120-5. PubMed ID: 9578746
    [No Abstract]   [Full Text] [Related]  

  • 27. Does chemotherapy augment anti-tumor immunotherapy by preferential impairment of regulatory T cells?
    Zhang L; Dermawan KT; Jin ML; Xiong SD; Chu YW
    Med Hypotheses; 2008 Nov; 71(5):802-4. PubMed ID: 18691831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Theoretical and experimental bases for the complex treatment of neoplasms].
    Kavetskiĭ RE
    Vopr Onkol; 1973; 19(1):10-7. PubMed ID: 4121907
    [No Abstract]   [Full Text] [Related]  

  • 29. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy.
    Minor DR; Moore D; Kim C; Kashani-Sabet M; Venna SS; Wang W; Boasberg P; O'Day S
    Oncologist; 2009 Oct; 14(10):995-1002. PubMed ID: 19776094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Present state of immunotherapy of tumours (author's transl)].
    Rieche K
    Arch Geschwulstforsch; 1974; 44(2):167-81. PubMed ID: 4375452
    [No Abstract]   [Full Text] [Related]  

  • 31. [Medical therapy of neoplastic disease. Polychemotherapy and aspecific, active immunostimulation].
    Saccani F; Becchi G
    Minerva Med; 1973 Jan; 64(2):71-5. PubMed ID: 4687731
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immunotherapy in radical surgery of colorectal carcinoma].
    Brivio F; Fumagalli L; Chiarelli M; Denova M; Bertolini A; Cetta M; Nespoli A
    Chir Ital; 2007; 59(5):635-40. PubMed ID: 18019635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FOCUS on FOCIS: combined chemo-immunotherapy for the treatment of hormone-refractory metastatic prostate cancer.
    Rozková D; Tiserová H; Fucíková J; Last'ovicka J; Podrazil M; Ulcová H; Budínský V; Prausová J; Linke Z; Minárik I; Sedivá A; Spísek R; Bartůnková J
    Clin Immunol; 2009 Apr; 131(1):1-10. PubMed ID: 19201656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer chemotherapy-induced lymphocytosis: a revolutionary discovery in the medical oncology.
    Lissoni P; Fumagalli L; Brivio F; Rovelli F; Messina G; Di Fede G; Colciago M; Brera G
    J Biol Regul Homeost Agents; 2006; 20(1-2):29-35. PubMed ID: 18088552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2) immunotherapy with ranimustine chemotherapy and concurrent radiation therapy for malignant astrocytomas.
    Fukushima T; Yamamoto M; Oshiro S; Tsugu H; Hirakawa K; Soma G
    Anticancer Res; 2003; 23(6a):4473-81. PubMed ID: 14666736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The legacy of cancer therapy in children.
    Fox E; Citrin D; Balis FM
    J Natl Cancer Inst; 2009 Aug; 101(16):1105-7. PubMed ID: 19648512
    [No Abstract]   [Full Text] [Related]  

  • 37. Long-term outcome of immunotherapy for patients with refractory pancreatic cancer.
    Nakamura M; Wada J; Suzuki H; Tanaka M; Katano M; Morisaki T
    Anticancer Res; 2009 Mar; 29(3):831-6. PubMed ID: 19414316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of cytokines on high dose chemotherapy followed by transplantation of purified and ex vivo expanded peripheral blood stem cells: achieving a state of minimal residual disease for tumor immunotherapy with cytokine gene transfected cells.
    Mertelsmann R
    Eur Cytokine Netw; 1995; 6(2):79-82. PubMed ID: 7578991
    [No Abstract]   [Full Text] [Related]  

  • 39. Angiosarcoma of the scalp treated with curative radiotherapy plus recombinant interleukin-2 immunotherapy.
    Ohguri T; Imada H; Nomoto S; Yahara K; Hisaoka M; Hashimoto H; Tokura Y; Nakamura K; Shioyama Y; Honda H; Terashima H; Moroi Y; Furue M; Korogi Y
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1446-53. PubMed ID: 15817349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Current status and prospects of the clinical chemotherapy of tumorous diseases].
    Perevodchikova NI
    Vestn Akad Med Nauk SSSR; 1986; (5):3-8. PubMed ID: 2425507
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.